Mikki Ozawa

488 citations
5 papers · 288 indexed · h-index 5
Topics
Renal Transplantation Outcomes and Treatments (4 papers)Organ Transplantation Techniques and Outcomes (2 papers)Monoclonal and Polyclonal Antibodies Research (2 papers)
Journals
TransplantationPubMed

In The Last Decade

Mikki Ozawa

5 papers receiving 274 citations

Peers

Mikki Ozawa
Comparison fields: 5 of 40
  • Transplantation 174
  • Surgery 170
  • Immunology 69
  • Nephrology 49
  • Hepatology 47
Replace Peter A. Rowe with:
Peter A. Rowe United Kingdom
Van Buren Ct United States
Chow Heok P’ng Australia
Khaled Hamawi United States
Haruka Shinke Japan
Jeremy Schwieger United States
V.T. Yılmaz Türkiye
Christophe Gerbeau Switzerland
Ranjeeta Bahirwani United States
Kazuya Kabei Japan
Mikki Ozawa relative to Peter A. Rowe United Kingdom Peter A. Rowe's profile →
Citations per field
00.5×
Peter A. Rowe · 1×
Citations per year

Countries citing papers authored by Mikki Ozawa

Since Specialization
Citations

This map shows the geographic impact of Mikki Ozawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikki Ozawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikki Ozawa more than expected).

Fields of papers citing papers by Mikki Ozawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikki Ozawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikki Ozawa. The network helps show where Mikki Ozawa may publish in the future.

Co-authorship network of co-authors of Mikki Ozawa

This figure shows the co-authorship network connecting the top 25 collaborators of Mikki Ozawa. A scholar is included among the top collaborators of Mikki Ozawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikki Ozawa. Mikki Ozawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
#WorkIndexed citations
1 47
2
Epitopes of HLA-A, B, C, DR, DQ, DP and MICA antigens.
35
3
HLA class II DQ epitopes.
11
4
Detection of HLA and MICA antibodies before kidney graft failure.
13
5 182

About Mikki Ozawa

Mikki Ozawa is a scholar working on Transplantation, Physiology and Nephrology, having authored 5 papers that have together received 288 indexed citations. Recurring topics across this work include Renal Transplantation Outcomes and Treatments (4 papers), Organ Transplantation Techniques and Outcomes (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Transplantation (174 citations), Nephrology (49 citations) and Hepatology (47 citations). Mikki Ozawa has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Paul I. Terasaki, Gabriel M. Danovitch, David Chia, Alan Wilkinson, Xiuming Wang, Arthur H. Cohen, Masaru Hirata, S Katznelson, Jon Kobashigawa and Kimberly P. Briley. Their work appears in journals such as Transplantation and PubMed.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026